Journals / Turkish Journal of Medical Sciences / 2021 / Cilt: 51 - Sayı: 4

Attention-deficit hyperactivity disorder symptoms and quality of life in female patients with fibromyalgia

Pages
1747–1755
Publication Date
2022-11-01
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Results: It was found that the FM group had significantly higher scores on the ASRS than the control group (p < 0.05).

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Background/aim: The present study aimed to determine the association between attention-deficit hyperactivity disorder (ADHD) symptoms severity, fibromyalgia (FM) severity, and QoL.
📊
Key Findings & Data:Materials and methods: While the FM group consisted of 113 (74%) patients, the control group consisted of 40 (26%) individuals.
💡
Conclusion & Impact:Results: It was found that the FM group had significantly higher scores on the ASRS than the control group (p < 0.05).
🔬Design:Survey & Empirical Study
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Background/aim: The present study aimed to determine the association between attention-deficit hyperactivity disorder (ADHD) symptoms severity, fibromyalgia (FM) severity, and QoL. Materials and methods: While the FM group consisted of 113 (74%) patients, the control group consisted of 40 (26%) individuals. FM symptom severity, ADHD symptom severity, and QoL were evaluated using the fibromyalgia impact questionnaire (FIQ), adult ADHD self-report scale (ASRS), and World Health Organization quality of life scale-brief version (WHOQOL-BREF), respectively. Results: It was found that the FM group had significantly higher scores on the ASRS than the control group (p < 0.05). There was a significant difference in FIQ scores and three WHOQOL-BREF domain scores between the FM alone and comorbid FM/high probability of ADHD groups (p < 0.05). We found a negative correlation between ASRS total scores and all other scale scores (except for the social relationships domain score of the WHOQOL-BREF) and a positive correlation between ASRS total scores and FIQ scores in FM patients. ADHD scores would mediate the relationship between depression severity and QoL. Conclusions: Our findings indicated that the presence of ADHD symptoms was related to greater FM symptom severity and poorer QoL. Also, ADHD scores would mediate the relationship between depression severity and QoL.Key words: Adult attention deficit hyperactivity disorder, fibromyalgia, quality of life

🔖

Cite This Article

TÜRKOĞLU, G., SELVİ, Y. (2022). Attention-deficit hyperactivity disorder symptoms and quality of life in female patients with fibromyalgia. Turkish Journal of Medical Sciences, Cilt: 51 - Sayı: 4, 1747–1755. https://ajindex.com/articles/609782

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (1)

  1. Polanczyk G, De Lima MS, Horta BL, Biederman J, Rohde LA. The worldwide prevalence of ADHD: a systematic review and metaregression analysis. American Journal of Psychiatry 2007; 164 (6): 942-948. doi: 10.1176/appi.ajp.164.6.942 2. Faraone SV, Biederman J, Mick E. The age-dependent decline of attention deficit hyperactivity disorder: a meta-analysis of follow-up studies. Psychological Medicine 2006; 36 (2): 159- 165. doi: 10.1017/S003329170500471X 3. Jensen CM, Steinhausen H-C. Comorbid mental disorders in children and adolescents with attention-deficit/ hyperactivity disorder in a large nationwide study. ADHD Attention Deficit and Hyperactivity Disorders 2015; 7 (1): 27-38. doi: 10.1007/ s12402-014-0142-1 4. Brainstorm C, Anttila V, Bulik-Sullivan B, Finucane HK, Walters RK et al. Analysis of shared heritability in common disorders of the brain. Science 2018; 22;3 60 (6395): eaap8757. doi: 10.1126/science.aap8757 5. Treister R, Eisenberg E, Demeter N, Pud D. Alterations in pain response are partially reversed by methylphenidate (Ritalin) in adults with attention deficit hyperactivity disorder (ADHD). Pain Practice 2015; 15 (1): 4-11. doi: 10.1111/papr.12129 6. Clauw DJ. Fibromyalgia and related conditions. Mayo Clinic Proceedings 2015; 90 (5): 680-692. doi: 10.1016/j. mayocp.2015.03.014 7. Weir PT, Harlan GA, Nkoy FL, Jones SS, Hegmann KT et al. The incidence of fibromyalgia and its associated comorbidities: a population-based retrospective cohort study based on International Classification of Diseases, 9th Revision codes. JCR: Journal of Clinical Rheumatology 2006; 12 (3): 124-128. doi: 10.1097/01.rhu.0000221817.46231.18 8. Cabo-Meseguer A, Cerdá-Olmedo G, Trillo-Mata JL. Fibromyalgia: prevalence, epdemiologic profiles and economic costs. Medicina Clinica 2017; 149 (10): 441-448. doi: 10.1016/j. medcli.2017.06.008 9. Queiroz LP. Worldwide epidemiology of fibromyalgia. Current Pain and Headache Reports 2013; 17 (8): 356. doi: 10.1007/ s11916-013-0356-5 10. Goldenberg D, Schur P, Romain P. Clinical manifestations and diagnosis of fibromyalgia in adults. Literature Review UpToDate 2016. 11. Buskila D, Sarzi-Puttini P. Biology and therapy of fibromyalgia, genetic aspects of fibromyalgia syndrome. Arthritis Research & Therapy 2006; 8 (5): 218. doi: 10.1186/ar2005 12. Bellato E, Marini E, Castoldi F, Barbasetti N, Mattei L et al. Fibromyalgia syndrome: etiology, pathogenesis, diagnosis, and treatment. Pain Research and Treatment 2012; 2012: 1-17. doi: 10.115